Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00025265
DRKS00025265
Recruiting
未知

Impact of a VA-ECMO in combination with an extracorporeal cytokine hemadsorption system in critically ill patients with cardiogenic shock.A prospective, randomized, controlled, blinded, monocenter, trial - ECMOsorb

niversitätsklinikum Jena KIM I, Kardiologie0 sites54 target enrollmentMay 12, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsR57.0Cardiogenic shock

Overview

Phase
未知
Intervention
Not specified
Conditions
R57.0
Sponsor
niversitätsklinikum Jena KIM I, Kardiologie
Enrollment
54
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 12, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Jena KIM I, Kardiologie

Eligibility Criteria

Inclusion Criteria

  • •Critically ill patients with cardiogenic shock with or without reanimation (CPR),
  • •\- indication for VA\-ECMO,
  • •\- age \=18 years \=80 years.
  • •\- signed informed consent

Exclusion Criteria

  • •Contraindications to VA\-ECMO implantation.
  • •Patients with pre – existing sepsis (raised CRP, positive PCT, leukocytosis, fever, positive blood cultures).
  • •Shock duration\> 12 h before evaluation.
  • •Severe PVD (peripheral vessel disease) making ECMO\-implantation impossible.
  • •Aortic valve insufficiency / stenosis at least II °.
  • •Age \<18, \> 80 years.
  • •CNS disease with fixed, dilated pupils (not drug\-induced).
  • •Severe concomitant disease with limited life expectancy \<6 months.
  • •Participation in another study.
  • •CPR\> 60min.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic ShockCardiogenic Shock
NCT05027529Christian Schulze42
Recruiting
Not Applicable
Outcomes of Patients With Venoarterial Extracorporeal Membrane OxygenationCardiogenic ShockCardiac Arrest
NCT04039594Beijing Anzhen Hospital500
Not yet recruiting
Not Applicable
Percutaneous versus surgical VA ECMO insertion: a pilot study to evaluate feasibility and safetyacute heart failurecardiogenic shock10019280
NL-OMON53934Amsterdam UMC30
Not yet recruiting
Not Applicable
Prognostic Value of Combined Central Venous Oxygen Saturation and Lactate in Pediatrics Following Cardiac Surgery.Circulatory SystemPaediatricsCardiology
PACTR202104905893217Facullty of medicine Menofia University70
Completed
Phase 2
Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry TrialCardiac FailureCritical Illness
NCT03841084Australian and New Zealand Intensive Care Research Centre300